Oregon voters will decide this November in favor of a statewide initiative to regulate the commercial production and retail sale of marijuana.
The proposed ballot initiative (Initiative Petition 53) seeks to regulate the personal possession, commercial cultivation, and retail sale of cannabis to adults. Taxes on the commercial sale of cannabis under the plan are estimated to raise some $88 million in revenue in the first two years following the law’s implementation. Adults who engage in the non-commercial cultivation of limited amounts of cannabis for personal use (up to four marijuana plants and eight ounces of usable marijuana at a given time) will not be subject to taxation or commercial regulations.
Passage of the initiative would not “amend or affect in any way the function, duties, and powers of the Oregon Health Authority under the Oregon Medical Marijuana Act.”
A statewide Survey USA poll released in June reported that 51 percent of Oregon adults support legalizing the personal use of marijuana. Forty-one percent of respondents, primarily Republicans and older voters, oppose the idea. The poll did not survey respondents as to whether they specifically supported the proposed 2014 initiative.
Alaska voters will decide on a similar legalization initiative in November. Florida voters will also decide in November on a constitutional amendment to allow for the physician-authorized use of cannabis therapy.
This afternoon, the House of Representatives voted 231 to 192 in favor of the Heck-Perlmutter-Lee-Rohrabacher Amendment, which will restrict Treasury Department and SEC funds from being spent to penalize financial institutions for providing services to marijuana related business that operate according to state law. This proposal amends H.R. 5016, a spending bill for fiscal year 2015 that funds the Internal Revenue Service, Treasury Department, and Securities and Exchange Commission.
The amendment reads:
“None of the funds made available in this Act may be used, with respect to the States of Alabama, Alaska, Arizona, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Illinois, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, Oregon, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Washington, or Wisconsin or the District of Columbia, to prohibit, penalize, or otherwise discourage a financial institution from providing financial services to an entity solely because the entity is a manufacturer, producer, or person that participates in any business or organized activity that involves handling marijuana or marijuana products and engages in such activity pursuant to a law established by a State or a unit of local government.”
This vote comes on the heels of another recent historic vote in the House of Representatives, that restricted Department of Justice and DEA funds from being used to interfere in state approved medical marijuana programs. That measure is still awaiting action in the US Senate. This measure, HR 5106, will now be sent to the Senate as well.
“The recent votes in the House of Representatives demonstrate bi-partisan support at the federal level to allow states to experiment with new marijuana policies, free from federal interference,” stated NORML Communications Director Erik Altieri, “If implemented, this amendment will help alter the current untenable status quo that forces otherwise law abiding businesses to operate on a cash only basis, making them a target for criminal actions and unduly burdening their operations.”
NORML has been fighting for nearly half a century to replace our nation’s overreaching, under-serving and (by any objective measure) disastrous marijuana laws with a sensible, regulated retail system – and in 2014, real change is finally upon us. The effective launch of Colorado and Washington State’s new cannabis market is a clear indication that the days of prohibition are numbered. Marijuana is now a true commercial commodity, and with that comes a new set of standards – the likes of which the industry, and the movement have never seen before.
As a result of the commercialization of this new industry, NORML is pleased to announce the launch of the NORML Business Network, a new initiative seeking to bridge consumer advocacy with the cannabis industry. The Network will be collaborating with marijuana companies and ancillary businesses that are committed to using their enterprise as a positive example of corporate social responsibility, and a platform for ending marijuana prohibition nationwide. The NORML Business Network has already partnered with Weedmaps, Marijuana.com and High Times Magazine to further promote this initiative, and to highlight other members of the NORML Business Network through their various mediums.
The NORML Business Network is a selective, industry focused, membership-based program that advocates for high industry standards, and using business as a force for change. The Network’s mission is to empower the market early on to become invested in creating a culture of self-regulation, and to encourage entities to adopt a socially conscious corporate model that integrates the interests of their customers and communities into the fabric of their business’ DNA. Similar to that of the Better Business Bureau, stores or products that carry the NORML Business Partner seal confirms that they are operating a “values-driven” enterprise, and are active supporters of marijuana law reform nationwide. NORML Business Partners will be required to meet certain criteria, including various market and industry qualifiers such as testing, labeling, environmental sustainability, fair wages, decent pricing and special discounts for certain populations such as seniors and veterans.
The cannabis industry is under more scrutiny than any other developing market has ever been, and it is critical for all stakeholders to remain cognizant of this enduring challenge. The public as well as lawmakers will be watching closely at how these new policies in Colorado and Washington affect the communities and environments of those states, and beyond their borders. How retail marijuana unfolds in these early years will determine the future course of legalization nationwide.
As a consumer advocacy nonprofit, NORML is dedicated to identifying and protecting all new and evolving stakeholder interests – while also continuing on the path to legalization nationwide. The organization recognizes that the implementation of Colorado and Washington State’s commercial retail cannabis market have permanently changed the scope of the consumer advocacy debate, and the NORML Business Network is a natural evolution for the forty-five year old organization. The evolution of this burgeoning industry is creating entirely new legal and logistical challenges, which call for new standards and industry accountability – and NORML will continue to advocate for consumer’s interests under a legal regime.
“We want to recognize the positive impact these marijuana businesses are having on their communities by highlighting those who go above and beyond the letter of the law in an effort to align their economic benefits alongside the interests of their customers and communities,” said Sabrina Fendrick, NORML’s Director of Strategic Partnerships.
The NORML Business Network will promote these good corporate citizens to a national audience, media, elected official and the public safety community, amplifying their work as positive examples of the marijuana industry. This in turn will help solidify the integrity of legalization as public policy, and ensure the sustainability of the industry as reform takes root nationwide. For more information visit www.norml.org/business.
I’m sometimes asked how a midwestern farm-boy ended up starting a marijuana smokers’ lobby. I had been raised in the 1950s in southern Illinois by southern Baptist parents, and there was nothing in that environment that would cause one to challenge authority or attempt to change the prevailing cultural values.
But then came the Vietnam War. Like many young men of my generation who came of age during that war, I had been radicalized by the war, or more specifically, by the threat of being drafted and sent to fight in Vietnam, a war few of us understood and even fewer wanted to die for (58,000 Americans eventually died in Vietnam). My primary focus at the time was avoiding the war in any way possible – a “draft dodger” was the derogatory term used for those of us who did not wish to serve.
Back then, before the draft lottery had even been established, all young men, by the time they were 18 years of age, were required to register for the draft, and unless they were a full-time student, were promptly inducted. So many of us stayed in school for as long as possible, but we remained subject to the draft until we turned 27 years of age. So when I graduated law school in 1968 at 25, I immediately received my draft notice, passed my physical, and was only two weeks away from my report date, when, with the help of some dedicated lawyers working with the National Lawyers’ Guild, I managed to get what was called a critical-skills deferment, that allowed me to spend my two years working at a presidential commission in Washington, DC, instead of getting shot in Vietnam.
In a memo obtained by NORML, released in late May, the United States Department of Agriculture (USDA) clarified their drug policy in light of the growing number of states legalizing marijuana for medical and recreational use.
In response to inquiries regarding the department’s policy for employees in states that approved recreational or medical use of marijuana, the USDA strongly reaffirmed that their drug testing policies concerning marijuana are still very much in effect, regardless of state law changes.
The memo states that, “use of Marijuana for ‘recreational’ purposes is not authorized under Federal law nor the Department’s Drug Free Workplace Program policies.” It then elaborates that, “accordingly, USDA testing procedures remain in full force and effect.”
This policy is largely still being enforced due to marijuana’s current status as a Schedule I drug at the federal level. The USDA described their current ongoing policy by stating that “USDA agencies test for the following class of drugs and their metabolites: (a) Marijuana, Opiate (Codeine/Morphine, Morphine, 6-Acetylmorphine) and PCP; and (b) Cocaine, Amphetamines (AMP/MAMP, Methamphetamine, MDMA). These drugs are listed in the Controlled Substances Act (CSA)…as Schedule I and Schedule II drugs, respectively. Schedule I drugs are substances, or chemicals defined as drugs with no currently accepted medical use and a high potential for abuse. They are considered the most dangerous of all the drug schedules and invite potentially severe psychological or physical dependence.”
Citing the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Medical Review Officer Manual for Federal Agency Workplace Testing Programs, the USDA also made clear this policy applies equally whether marijuana is being used for recreational use or medical purposes:
“State initiatives and laws, which make available to an individual a variety of illicit drugs by a physician’s prescription or recommendation, do not make the use of these illicit drugs permissible under the Federal Drug-Free Workplace Program. These State initiatives and laws are inconsistent with Federal law and put the safety, health, and security of Federal works and the American public at risk. The use of any substance included in Schedule I of the CSA, whether for non-medical or ostensible medical purposes, is considered a violation of Federal law and the Federal Drug-Free Workplace Program.”
“The USDA’s stance on testing employees for marijuana use, regardless of the laws of the state in which they live, is unfortunate,” stated NORML Communications Director Erik Altieri, “Patients will be denied effective medicine and individuals will be denied civil liberties being given to their fellow state citizens. This situation highlights the fact that the existing, inherent conflict between state laws seeking to legalize and regulate cannabis for recreational or medical purposes and federal policy, which classifies the substance as illicit, are ultimately untenable. To resolve this conflict there must be a change in marijuana’s federal classification. Without such a change, we will consistently have a lack of clarity and ongoing conflict between public sentiment, state law, and federal policy.”
You can read the full USDA memo here.